ESTRO Annual Report 2020

RESEARCH

ESTRO is committed to support research that is relevant to its members. The scope of ESTRO involvement varies with the research topic, the type of research activity, and the level of support requested. On the next pages are explanations of research activities in which ESTRO was involved in 2020.

1. E 2 -RADIatE - EORTC-ESTRO radiation infrastructure for Europe programme

E²-RADIatE (EORTC 1811 study) is a platform that collects real-world data through prospective data registries in radiotherapy. It is a collaboration between EORTC and ESTRO that is in- tended to be an efficient pan-European infrastructure framework across the field of radiation oncology to generate robust data in cancer treatment and to develop and integrate the discipline further into therapeutic strategies.

E²-RADIatE comprises two innovative cohorts, OligoCare (EORTC 1822-RP) and ParticleCare (EORTC 1833-RP). A third cohort on Re-irradiation ReCare (EORTC 2011-RP) was initiated in 2020. E²-RADIatE (EORTC 1811) COUNTRY & SITE ACTIVATION As of 14 December 2020, 20 sites in six countries had been activated for E²-RADIatE and had opened for enrolment in OligoCare. Another 30-40 sites in 13 countries are planned for activation by the first half of next year. If you are interested in participating, please go to the website for more information. OligoCare (EORTC 1822-RP) Since June 2020, OligoCare has had a monthly enrolment of 30-40 patients. The aim is to enrol patient number 500 by March 2021.

30